New oral breast cancer drug has potential to combat other types of cancer

[News]

Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the Abramson Cancer Center in the University of Pennsylvania published this month in JAMA Oncology.

More... (http://www.news-medical.net/news/20151230/New-oral-breast-cancer-drug-has-potential-to-combat-other-types-of-cancer.aspx)